HIV (Human Immunodeficiency Virus) Therapeutics Market by Type, Product, and Geography - Forecast and Analysis 2019-2023

The global HIV therapeutics market has the potential to grow by USD 2.44 billion during 2019-2023, and the market’s growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW), type (combination therapy and monotherapy), and product (reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, integrase inhibitors, and coreceptor antagonists). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including AbbVie Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Lupin Ltd., Merck & Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Market Overview

Browse TOC and LoE with selected illustrations and example pages from HIV therapeutics market report

Request a FREE sample now!

Market Competitive Analysis

The market is concentrated, and the degree of concentration will decrease during the forecast period. The vendors are focusing on technological advancements in diagnostic testing and are increasingly funding the development of novel therapies. To expand their market reach, established vendors are also focusing on adopting strategic alliances. Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., and Merck & Co. Inc. are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the high cost of antiretroviral therapies will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this HIV therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this report also includes information on the upcoming HIV therapeutics market trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This HIV therapeutics market analysis report provides information on the production, sustainability, and prospects of several leading HIV therapeutics companies, including:

• AbbVie Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Lupin Ltd., Merck & Co. Inc.
• Mylan NV
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

HIV Therapeutics Market: Segmentation by Region